-
EP4499080
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4499080
| EP4499080 - 5-METHOXY-N,N-DIMETHYLTRYPTAMINE FOR THE TREATMENT OF POSTPARTUM DEPRESSION [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 03.01.2025 Database last updated on 08.04.2026 | |
| Former | The international publication has been made Status updated on 07.10.2023 | ||
| Former | unknown Status updated on 24.04.2023 | Most recent event Tooltip | 07.01.2026 | New entry: Renewal fee paid | Applicant(s) | For all designated states GH Research Ireland Limited Joshua Dawson House Dawson Street D02 RY95 Dublin 2 / IE | [2025/06] | Inventor(s) | 01 /
TERWEY, Theis 10119 Berlin / DE | 02 /
BURKE, Conor Laytown / IE | 03 /
GAFFNEY, Naoise Dublin / IE | [2025/06] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2025/06] | Breuer, Markus Sendlinger Straße 29 80331 München / DE | Application number, filing date | 23717040.2 | 27.03.2023 | [2025/06] | WO2023EP57874 | Priority number, date | EP20220000084 | 27.03.2022 Original published format: EP 22000084 | EP20220000085 | 27.03.2022 Original published format: EP 22000085 | EP20230153996 | 30.01.2023 Original published format: EP 23153996 | EP20230154014 | 30.01.2023 Original published format: EP 23154014 | [2025/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2023186827 | Date: | 05.10.2023 | Language: | EN | [2023/40] | Type: | A1 Application with search report | No.: | EP4499080 | Date: | 05.02.2025 | Language: | EN | The application published by WIPO in one of the EPO official languages on 05.10.2023 takes the place of the publication of the European patent application. | [2025/06] | Search report(s) | International search report - published on: | EP | 05.10.2023 | Classification | IPC: | A61K31/4045, A61K9/00, A61P25/24 | [2025/06] | CPC: |
A61K31/4045 (EP,IL,KR,US);
C07D209/16 (KR);
A61K9/0019 (EP,IL,KR);
A61K9/007 (EP,IL);
A61P25/00 (KR);
A61P25/24 (EP,IL,KR,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2025/06] | Title | German: | 5-METHOXY-N,N-DIMETHYLTRYPTAMIN ZUR BEHANDLUNG VON POSTPARTALER DEPRESSION | [2025/06] | English: | 5-METHOXY-N,N-DIMETHYLTRYPTAMINE FOR THE TREATMENT OF POSTPARTUM DEPRESSION | [2025/06] | French: | 5-MÉTHOXY-N, N-DIMÉTHYLTRYPTAMINE POUR LE TRAITEMENT DE LA DÉPRESSION POST-PARTUM | [2025/06] | Entry into regional phase | 28.10.2024 | National basic fee paid | 28.10.2024 | Designation fee(s) paid | 28.10.2024 | Examination fee paid | Examination procedure | 28.10.2024 | Examination requested [2025/06] | 28.10.2024 | Date on which the examining division has become responsible | 14.05.2025 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 27.02.2025 | Renewal fee patent year 03 | 06.01.2026 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [IY] WO2020169851 (GH RES LIMITED et al.) | [Y] US2022062238 (LAYZELL MARIE CLAIRE et al.) | [A] UTHAUG MALIN V. ET AL: "A comparison of reactivation experiences following vaporization and intramuscular injection (IM) of synthetic 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting", JOURNAL OF PSYCHEDELIC STUDIES, vol. 4, no. 2, 26 March 2020 (2020-03-26), pages 104 - 113, XP093055117, DOI: 10.1556/2054.2020.00123 DOI: http://dx.doi.org/10.1556/2054.2020.00123 | by applicant | WO2020169850 | MONTGOMERY, S. A.ASBERG, M: "A new depression scale designed to be sensitive to change", THE BRITISH JOURNAL OF PSYCHIATRY, vol. 134, 1979, pages 382 | LAKE, C. R.STIRBA, A. L.KINNEMAN, R. E. JRCARLSON, BHOLLOWAY, H. C.: "Mania associated with LSD ingestion", AMERICAN JOURNAL OF PSYCHIATRY, vol. 138, no. 11, 1981, pages 1508 - 9 | HENDIN, H.M.PENN, A. D.: "An episode of mania following self-reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: A case report", BIPOLAR DISORDERS, vol. 23, no. 4, 2021, pages 1 - 3 | SZMULEWICZ, A. G.VALERIO, M. P.JOSE MSMITH, J. M.: "Switch to mania after ayahuasca consumption in a man with bipolar disorder: a case report", INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, vol. 3, no. 4, 2015 | BROWN, TSHAO, WAYUB, SCHONG, DCORNELIUS, C: "A Physician's attempt to self-medicate bipolar depression with N, N-dimethyl-tryptamine (DMT", JOURNAL OF PSYCHOACTIVE DRUGS, vol. 49, no. 4, 2017, pages 294 - 296 | BADER, CYNTHIA DDAVID L. DUNNER: "Antidepressant-induced hypomania in treatment-resistant depression", JOURNAL OF PSYCHIATRIC PRACTICE, vol. 13, no. 4, 2007, pages 233 - 237 | "Melatonin and the Mammalian Pineal Gland", 1995, CHAPMAN & HALL, article "Biochemistry of the Pineal" | SLOMINSKI RSLOMINSKI AT: "Melatonin in the Promotion of Health", 2012, CRC PRESS, article "Synthesis and Metabolism of Melatonin in the Skin and Retinal Pigment Epithelium" | BIOCHEMICAL PHARMACOLOGY, vol. 36, pages 2235 - 2231 | BARRETT FS, J PSYCHOPHARMACOL, vol. 29, no. 11, 2015, pages 1182 - 90 | ROSEMAN L ET AL., FRONT PHARMACOL, vol. 8, 2018, pages 974 |